Jury Verdict Upheld In Amgen Cholesterol Drug Patent Row
An effort by drugmaker Sanofi to reverse a March jury verdict upholding cholesterol drug patents held by rival Amgen died Tuesday when a Delaware federal judge denied Sanofi's motions for judgment...To view the full article, register now.
Already a subscriber? Click here to view full article